7th annual anti cancer drug discovert & development summit

Venue: Sheraton Boston

Location: Boston, Massachusetts, United States

Event Date/Time: Jul 12, 2005 End Date/Time: Jul 13, 2005
Report as Spam

Description

THE PREMIER INFORMATION NETWORKING EVENT FOR INDUSTRIAL ONCOLOGY RESEARCHERS AND BUSINESS DEVELOPMENT PERSONNEL

The 7th Anti-Cancer Drug Discovery and Development Summit consists of the finest group of oncology experts from around the world to address the most promising avenues of investigation. An agenda well-balanced with therapeutic discovery & development programs coming from big pharma, biotechs & academia - this is the series most widely attended by high-level industrial cancer researchers, academic professors, and business development personnel worldwide since 1999, year after year.

What’s New at the 2005 Summit:

Latest Studies on Targeted Therapeutics:
OSI-930
SB-497115
VX-680
MEK Inhibitors
Updated Data on Angiogenesis Inhibitors, Antibodies & New Targets:
2C3
PTK787
VEGFR-Npn-1
CD22/CD20 Therapies
IMMU-110
Oncolytic Adenoviruses
Cyclin D1
Special Focus on Licensing, Partnering and Acquisitions in Oncology Business Development - See Day Two, Track B!

Featured Keynote Address:

The Challenges in Developing New Cancer Therapies

Louise Grochow
Global Medical Science Director, Oncology
ASTRAZENECA R&D BOSTON

PARTICIPANTS INCLUDE:

Actinium Pharmaceuticals, Inc.
Alfacell Corporation
Amgen, Inc.
AstraZeneca R&D Boston
Bayer Heathcare
Biogen Idec
Biomarker Technologies, LLC
Biovest International - An Accentia Company
Bristol Myers Squibb Company
Caprion Pharmaceuticals
Celera Genomics
Celgene Corporation
Celgene San Diego
Cell Genesys
Centocor, Inc.
Decision Options, LLC
Defined Health
Genzyme Corporation
GlaxoSmithKline
Immunogen, Inc.
Immunomedics, Inc.
Johnson & Johnson Pharmaceutical R&D
Merck Research Laboratories
Novartis Pharmaceuticals
OSI Pharmaceuticals, Inc.
Peregrine Pharmaceuticals
Pfizer Global Research & Development - Ann Arbor
Proctor & Gamble Pharmaceuticals
Rejuvenon
Sherris Pharma Partners
Veridex, LLC - A Johnson & Johnson Company
Dartmouth Medical School
Harvard Medical School Institute of Proteomics
UCLA David Geffen School of Medicine
University of Texas Southwestern Medical Center

Venue

39 Dalton Street
Boston
Massachusetts
United States
MORE INFO ON THIS VENUE